GlassScriptPhysician profile
Christopher P Hermann
NPI 1063469344
$1,101.16
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $69.59 · 2022: $202 · 2023: $316 · 2024: $24.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $216.90 | 2019-2023 | Farxiga, Breztri |
| Novo Nordisk INC | $174.72 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $172.86 | 2019-2024 | |
| Lilly USA, LLC | $108.75 | 2019-2023 | Mounjaro |
| Acadia Pharmaceuticals INC | $94.33 | 2023 | Nuplazid |
| Merck Sharp & Dohme LLC | $69.75 | 2019-2023 | Steglatro, Steglujan, Belsomra |
| Ironshore Pharmaceuticals INC. | $68.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.53 | 2019 | |
| Amgen INC. | $36.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $26.14 | 2022 | |
| Abbvie INC. | $24.36 | 2023 | |
| Abbott Laboratories | $23.02 | 2023 | Freestyle Libre 2 |
| Exact Sciences Corporation | $16.84 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $16.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.